{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:09:29Z","timestamp":1787580569912,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"crossref","award":["16-255"],"award-info":[{"award-number":["16-255"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2018YFC1315504"],"award-info":[{"award-number":["2018YFC1315504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background\n<\/jats:title>\n                <jats:p>Self-sampling HPV test and thermal ablation are effective tools to increase screening coverage and treatment compliance for accelerating cervical cancer elimination. We assessed the cost-effectiveness of their combined strategies to inform accessible, affordable, and acceptable cervical cancer prevention strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed a hybrid model to evaluate costs, health outcomes, and incremental cost-effectiveness ratios (ICER) of six screen-and-treat strategies combining HPV testing (self-sampling or physician-sampling), triage modalities (HPV genotyping, colposcopy or none) and thermal ablation, from a societal perspective. A designated initial cohort of 100,000 females born in 2015 was considered. Strategies with an ICER less than the Chinese gross domestic product (GDP) per capita ($10,350) were considered highly cost-effective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with current strategies in China (physician-HPV with genotype or cytology triage), all screen-and-treat strategies are cost-effective and self-HPV without triage is optimal with the most incremental quality-adjusted life-years (QALYs) gained (220 to 440) in rural and urban China. Each screen-and-treat strategy based on self-collected samples is cost-saving compared with current strategies (\u2212$818,430 to \u2212$3540) whereas more costs are incurred using physician-collected samples compared with current physician-HPV with genotype triage\u00a0(+$20,840 to +$182,840). For screen-and-treat strategies without triage, more costs (+$9404 to +$380,217) would be invested in the screening and treatment of precancerous lesions rather than the cancer treatment compared with the current screening strategies. Notably, however, more than 81.6% of HPV-positive women would be overtreated. If triaged with HPV 7 types or HPV16\/18 genotypes, 79.1% or 67.2% (respectively) of HPV-positive women would be overtreated with fewer cancer cases avoided (19 cases or 69 cases).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Screen-and-treat strategy using self-sampling HPV test linked to thermal ablation could be the most cost-effective for cervical cancer prevention in China. Additional triage with quality-assured performance could reduce overtreatment and remains highly cost-effective compared with current strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-02840-8","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T14:02:38Z","timestamp":1681740158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study"],"prefix":"10.1186","volume":"21","author":[{"given":"Xue-Lian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fa","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Zhi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-0005","authenticated-orcid":false,"given":"Fang-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2840_CR1","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva, Switzerland. 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/336583. Accessed 18 Oct 2022."},{"key":"2840_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","volume":"20","author":"KT Simms","year":"2019","unstructured":"Simms KT, Steinberg J, Caruana M, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: a modelling study. Lancet Oncol. 2019;20:394\u2013407.","journal-title":"Lancet Oncol"},{"key":"2840_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575\u201390.","journal-title":"Lancet"},{"key":"2840_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12916-021-01930-9","volume":"19","author":"C Xia","year":"2021","unstructured":"Xia C, Xu XQ, Zhao XL, et al. Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study. BMC Med. 2021;19:62.","journal-title":"BMC Med"},{"key":"2840_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jama.2020.16244","volume":"324","author":"JM Lemp","year":"2020","unstructured":"Lemp JM, De Neve JW, Bussmann H, et al. Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries. JAMA. 2020;324:1532\u201342.","journal-title":"JAMA"},{"key":"2840_CR6","unstructured":"World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva, Switzerland. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240002319. Accessed 18 Oct 2022."},{"key":"2840_CR7","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2214-109X(14)70354-7","volume":"3","author":"S Arrossi","year":"2015","unstructured":"Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3:e85-94.","journal-title":"Lancet Glob Health"},{"key":"2840_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1470-2045(19)30635-7","volume":"21","author":"LF Pinder","year":"2020","unstructured":"Pinder LF, Parham GP, Basu P, et al. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020;21:175\u201384.","journal-title":"Lancet Oncol"},{"key":"2840_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/ijc.32881","volume":"147","author":"XL Zhao","year":"2020","unstructured":"Zhao XL, Xu XQ, Duan XZ, et al. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in \u201ccolposcopy and treat\u201d approach: A population-based study in rural China. Int J Cancer. 2020;147:1275\u201385.","journal-title":"Int J Cancer"},{"key":"2840_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/ijc.33290","volume":"148","author":"XL Zhao","year":"2021","unstructured":"Zhao XL, Liu ZH, Zhao S, et al. Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China. Int J Cancer. 2021;148:1419\u201327.","journal-title":"Int J Cancer"},{"key":"2840_CR11","first-page":"322","volume":"26","author":"J Liu","year":"2020","unstructured":"Liu J, Wu L, Bai Q, Ren J, Shao H, Huang Z. Surveillance for coverage of human papillomavirus (HPV) vaccine and adverse events following immunization with HPV vaccine in Shanghai, 2017\u20132019. Chin J Vaccines Immunization. 2020;26:322\u20135.","journal-title":"Chin J Vaccines Immunization"},{"key":"2840_CR12","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1016\/S2468-2667(19)30162-8","volume":"4","author":"C Xia","year":"2019","unstructured":"Xia C, Hu S, Xu X, et al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health. 2019;4:e462\u201372.","journal-title":"Lancet Public Health"},{"key":"2840_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12874-018-0541-7","volume":"18","author":"K Haeussler","year":"2018","unstructured":"Haeussler K, den Hout AV, Baio G. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease. BMC Med Res Methodol. 2018;18:82.","journal-title":"BMC Med Res Methodol"},{"key":"2840_CR14","volume-title":"A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease","author":"KD Haeussler","year":"2017","unstructured":"Haeussler KD. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease. London: UCL (University College London); 2017."},{"key":"2840_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12885-016-2207-3","volume":"16","author":"YJ Liu","year":"2016","unstructured":"Liu YJ, Zhang Q, Hu SY, Zhao FH. Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China. BMC Cancer. 2016;16:164.","journal-title":"BMC Cancer"},{"key":"2840_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/sj.bjc.6602002","volume":"91","author":"K Canfell","year":"2004","unstructured":"Canfell K, Barnabas R, Patnick J, Beral V. The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. Br J Cancer. 2004;91:530\u20136.","journal-title":"Br J Cancer"},{"key":"2840_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ijc.11334","volume":"106","author":"SJ Goldie","year":"2003","unstructured":"Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine. Int J Cancer. 2003;106:896\u2013904.","journal-title":"Int J Cancer"},{"key":"2840_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jval.2015.08.010","volume":"18","author":"K Haeussler","year":"2015","unstructured":"Haeussler K, Marcellusi A, Mennini FS, et al. Cost-effectiveness analysis of universal human papillomavirus vaccination using a Dynamic Bayesian Methodology: The BEST II study. Value Health. 2015;18:956\u201368.","journal-title":"Value Health"},{"key":"2840_CR19","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","volume":"151","author":"ER Myers","year":"2000","unstructured":"Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151:1158\u201371.","journal-title":"Am J Epidemiol"},{"key":"2840_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0304-3835(02)00715-2","volume":"192","author":"Y Masatoshi","year":"2003","unstructured":"Masatoshi Y, Tsuyoshi I, Chisato N, et al. Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett. 2003;192:171\u20139.","journal-title":"Cancer Lett"},{"key":"2840_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamainternmed.2019.0299","volume":"179","author":"GF Sawaya","year":"2019","unstructured":"Sawaya GF, Sanstead E, Alarid-Escudero F, et al. Estimated quality of life and economic outcomes associated with 12 cervical cancer screening strategies: A cost-effectiveness analysis. JAMA Intern Med. 2019;179:867\u201378.","journal-title":"JAMA Intern Med"},{"key":"2840_CR22","unstructured":"ICO\/IARC Information Centre on HPV and Cancer. Human papillomavirus and related diseases in China: HPV Information Centre. 2018. https:\/\/hpvcentre.net\/. Accessed 18 Oct 2022."},{"key":"2840_CR23","volume-title":"2016 China health statistics yearbook","author":"National Health and Family Planning Commission","year":"2016","unstructured":"National Health and Family Planning Commission. 2016 China health statistics yearbook. Beijing: Peking Union Medical College Press; 2016."},{"key":"2840_CR24","volume-title":"2018 China Cancer Registry Annual Report","author":"J He","year":"2019","unstructured":"He J. 2018 China Cancer Registry Annual Report. Beijing: People\u2019s Medical Publishing House; 2019."},{"key":"2840_CR25","unstructured":"National Bureau of Statistics of China. National data. http:\/\/data.stats.gov.cn\/english\/. Accessed 21 Oct 2022."},{"key":"2840_CR26","volume-title":"China population and employment statistics yearbook 2016","author":"National Bureau of Statistics of China","year":"2017","unstructured":"National Bureau of Statistics of China. China population and employment statistics yearbook 2016. Beijing: China Statistics Press; 2017."},{"key":"2840_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1158\/1940-6207.CAPR-17-0088","volume":"10","author":"L Dong","year":"2017","unstructured":"Dong L, Hu SY, Zhang Q, et al. Risk prediction of cervical cancer and precancers by type-specific human papillomavirus: evidence from a population-based cohort study in China. Cancer Prev Res (Phila). 2017;10:745\u201351.","journal-title":"Cancer Prev Res (Phila)"},{"key":"2840_CR28","doi-asserted-by":"publisher","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","volume":"4","author":"PT Yeh","year":"2019","unstructured":"Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019;4:e001351.","journal-title":"BMJ Glob Health"},{"key":"2840_CR29","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMsa044278","volume":"353","author":"SJ Goldie","year":"2005","unstructured":"Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353:2158\u201368.","journal-title":"N Engl J Med"},{"key":"2840_CR30","unstructured":"National Bureau of Statistics. China's 6th National Population Census. 2011. http:\/\/www.stats.gov.cn\/tjsj\/pcsj\/rkpc\/6rp\/indexch.htm. Accessed 12 Oct 2022."},{"key":"2840_CR31","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/ijc.33001","volume":"147","author":"R Rezhake","year":"2020","unstructured":"Rezhake R, Chen F, Hu SY, et al. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China. Int J Cancer. 2020;147:2053\u201364.","journal-title":"Int J Cancer"},{"key":"2840_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/ijgc-00009577-200311000-00013","volume":"13","author":"JL Belinson","year":"2003","unstructured":"Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer. 2003;13:819\u201326.","journal-title":"Int J Gynecol Cancer"},{"key":"2840_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Wiercioch W, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2016;132:266\u201371.","journal-title":"Int J Gynaecol Obstet"},{"key":"2840_CR34","unstructured":"Sexuality of Chinese 2000\u20132015: main results from four national population sampling surveys. Hong Kong: 1908 Company Limited: Pan S; 2017."},{"key":"2840_CR35","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1002\/ijc.27571","volume":"131","author":"FH Zhao","year":"2012","unstructured":"Zhao FH, Lewkowitz AK, Hu SY, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012;131:2929\u201338.","journal-title":"Int J Cancer"},{"key":"2840_CR36","first-page":"154","volume":"41","author":"JR Peng","year":"2019","unstructured":"Peng JR, Tao SY, Wen Y, Yang X, Ma JQ, Zhao F. Cost-effectiveness analysis of cervical cancer screening strategies in urban China. Chin J Oncol. 2019;41:154\u201360.","journal-title":"Chin J Oncol"},{"key":"2840_CR37","first-page":"1281","volume":"52","author":"SY Tao","year":"2018","unstructured":"Tao SY, Peng JR, Wang Y, et al. Study on direct economic burden and influencing factors in patients with cervical cancer and precancerous lesions. Chi J Prev Med. 2018;52:1281\u20136.","journal-title":"Chi J Prev Med"},{"key":"2840_CR38","doi-asserted-by":"publisher","first-page":"974","DOI":"10.21147\/j.issn.1000-9604.2019.06.13","volume":"31","author":"L Ma","year":"2019","unstructured":"Ma L, Wang Y, Gao X, et al. Economic evaluation of cervical cancer screening strategies in urban China. Chin J Cancer Res. 2019;31:974\u201383.","journal-title":"Chin J Cancer Res"},{"key":"2840_CR39","unstructured":"Wen TM, Zhao S, Zhao XL, et al. Investigation on quality of life of women with different grades of cervical lesions and treatments. Chin J Clin Obstet Gynecol 2023;24:144-8."},{"key":"2840_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L Value Set for China. Value Health. 2017;20:662\u20139.","journal-title":"Value Health"},{"key":"2840_CR41","unstructured":"National Bureau of Statistics of China. Residents' income and consumption expenditure in 2019. 2020. http:\/\/www.stats.gov.cn\/tjsj\/zxfb\/202001\/t20200117_1723396.html. Accessed 11 Oct 2022."},{"key":"2840_CR42","unstructured":"China Hainan Government Procurement. Hainan Women's and Children's Medical Center - HPV testing reagents and related services for women's common diseases and \"two cancers\" in 2019 -bid winning announcement. 2020. https:\/\/www.ccgp-hainan.gov.cn\/cgw\/cgw_show_zbgg.jsp?id=21831. Accessed 12 Oct 2022."},{"key":"2840_CR43","unstructured":"Zhejiang Government Procurement Center. Announcement of bid winning (transaction) results of \"two cancer\" examination project of provincial Health Commission, HPV and TCT test reagent project. 2020. http:\/\/zfcg.czt.zj.gov.cn\/innerUsed_noticeDetails\/index.html?noticeId=6604290. Accessed 15 Oct 2022."},{"key":"2840_CR44","unstructured":"Jiangsu Public Resource Trading Platform. TCT and HPV test service project of \"two cancers\" program in Tongzhou District, Nantong City. 2020. http:\/\/jsggzy.jszwfw.gov.cn\/jyxx\/003004\/003004002\/20200421\/f67ce97c-e4f6-44b3-977e-4bc17d5930df.html. Accessed 15 Oct 2022."},{"key":"2840_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/heapol\/czaa073","volume":"35","author":"M Haacker","year":"2020","unstructured":"Haacker M, Hallett TB, Atun R. On discount rates for economic evaluations in global health. Health Policy Plan. 2020;35:107\u201314.","journal-title":"Health Policy Plan"},{"key":"2840_CR46","unstructured":"World Health Organization. Macroeconomics and health: investing in health for economic development: report of the 588 commission on macroeconomics and health. Geneva, Switzerland. 2001. https:\/\/www.who.int\/publications\/i\/item\/924154550X. Accessed 21 Oct 2022."},{"key":"2840_CR47","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva, Switzerland.2021. https:\/\/www.who.int\/publications\/i\/item\/9789240040434. Accessed 21 Oct 2022."},{"key":"2840_CR48","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses. BMJ. 2018;363:k4823.","journal-title":"BMJ"},{"key":"2840_CR49","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1001\/jama.294.17.2173","volume":"294","author":"L Denny","year":"2005","unstructured":"Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TCJ. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA. 2005;294:2173\u201381.","journal-title":"JAMA"},{"key":"2840_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.12688\/gatesopenres.13201.1","volume":"4","author":"YL Chi","year":"2020","unstructured":"Chi YL, Blecher M, Chalkidou K, et al. What next after GDP-based cost-effectiveness thresholds? Gates Open Res. 2020;4:176.","journal-title":"Gates Open Res"},{"key":"2840_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(09)61757-8","volume":"375","author":"LK Borysiewicz","year":"2010","unstructured":"Borysiewicz LK. Prevention is better than cure. Lancet. 2010;375:513\u201323.","journal-title":"Lancet"},{"issue":"7","key":"2840_CR52","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/cam4.1089","volume":"6","author":"M Kunckler","year":"2017","unstructured":"Kunckler M, Schumacher F, Kenfack B, et al. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach. Cancer Med. 2017;6(7):1752\u201361.","journal-title":"Cancer Med"},{"key":"2840_CR53","first-page":"1875","volume":"101","author":"XL Zhao","year":"2021","unstructured":"Zhao XL, Zhao S, Hu SY, et al. Effectiveness of the thermal ablation in the treatment of human papillomavirus infection and cervical intraepithelial neoplasia in Chinese women. Natl Med J China. 2021;101:1875\u201381.","journal-title":"Natl Med J China"},{"key":"2840_CR54","first-page":"110","volume":"49","author":"Y Qiao","year":"2015","unstructured":"Qiao Y. Screening technologies to advance rapid testing for cervical cancer prevention in developing countries. Chi J Prev Med. 2015;49:110\u20131.","journal-title":"Chi J Prev Med"},{"key":"2840_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.46234\/ccdcw2020.128","volume":"2","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhong Y, Zhao Z, et al. Cervical cancer screening rates among Chinese women - China, 2015. China CDC Weekly. 2020;2:481\u20136.","journal-title":"China CDC Weekly"},{"key":"2840_CR56","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(19)32136-1","volume":"394","author":"W Yip","year":"2019","unstructured":"Yip W, Fu H, Chen AT, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394:1192\u2013204.","journal-title":"Lancet"},{"key":"2840_CR57","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ijc.29438","volume":"137","author":"NG Campos","year":"2015","unstructured":"Campos NG, Maza M, Alfaro K, et al. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer. 2015;137:893\u2013902.","journal-title":"Int J Cancer"},{"key":"2840_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-017-3786-3","volume":"17","author":"NG Campos","year":"2017","unstructured":"Campos NG, Tsu V, Jeronimo J, et al. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study. BMC Cancer. 2017;17:791.","journal-title":"BMC Cancer"},{"key":"2840_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12962-017-0075-6","volume":"15","author":"MR Zimmermann","year":"2017","unstructured":"Zimmermann MR, Vodicka E, Babigumira JB, et al. Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya. Cost Eff Resour Alloc. 2017;15:13.","journal-title":"Cost Eff Resour Alloc"},{"key":"2840_CR60","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/1055-9965.EPI-16-0787","volume":"26","author":"NG Campos","year":"2017","unstructured":"Campos NG, Jeronimo J, Tsu V, et al. The Cost-effectiveness of visual triage of human papillomavirus-positive women in three low- and middle-income countries. Cancer Epidemiol Biomarkers Prev. 2017;26:1500\u201310.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02840-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T15:08:19Z","timestamp":1681744099000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02840-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02840-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}